Total Payments
$4,365
2024 Payments
$293.40
Companies
42
Transactions
244
Medicare Patients
1,167
Medicare Billing
$108,473
Payment Breakdown by Category
Food & Beverage$3,913 (89.6%)
Education$451.89 (10.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,913 | 229 | 89.6% |
| Education | $451.89 | 15 | 10.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $579.50 | 25 | $0 (2024) |
| ABBVIE INC. | $560.84 | 37 | $0 (2023) |
| PFIZER INC. | $416.32 | 25 | $0 (2024) |
| Channel Medsystems, Inc. | $218.00 | 2 | $0 (2023) |
| Novo Nordisk Inc | $205.19 | 13 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $190.16 | 13 | $0 (2020) |
| BOSTON SCIENTIFIC CORPORATION | $154.22 | 3 | $0 (2017) |
| TherapeuticsMD, Inc. | $137.37 | 8 | $0 (2022) |
| Myovant Sciences Inc. | $136.53 | 9 | $0 (2022) |
| MAYNE PHARMA INC. | $135.30 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $293.40 | 17 | PFIZER INC. ($57.52) |
| 2023 | $766.43 | 35 | Astellas Pharma US Inc ($316.57) |
| 2022 | $1,107 | 51 | Channel Medsystems, Inc. ($185.22) |
| 2021 | $537.25 | 36 | AbbVie Inc. ($184.11) |
| 2020 | $274.61 | 18 | AbbVie Inc. ($75.66) |
| 2019 | $436.58 | 27 | PFIZER INC. ($89.03) |
| 2018 | $434.97 | 31 | AMAG Pharmaceuticals, Inc. ($110.54) |
| 2017 | $514.61 | 29 | BOSTON SCIENTIFIC CORPORATION ($154.22) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Biological | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: HORMONE THERAPY | ||||||
| 11/20/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 08/27/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Urology | ||||||
| 08/19/2024 | PFIZER INC. | DUAVEE (Drug), MYFEMBREE | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 08/15/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/08/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Biological | ||||||
| 07/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Obesity | ||||||
| 07/22/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $6.19 | General |
| 05/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: UROLOGY | ||||||
| 05/22/2024 | Hologic Sales and Service, LLC | CoolSeal Generator (Device), MYOSURE TISSUE REMOVAL DEVICE | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Surgical | ||||||
| 05/16/2024 | PFIZER INC. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);WOMENS HEALTH | ||||||
| 03/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Biological | ||||||
| 02/26/2024 | MILLICENT US INC | INTRAROSA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 01/24/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: HORMONE THERAPY | ||||||
| 01/09/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: WOMENS HEALTH | ||||||
| 01/04/2024 | Minerva Surgical, Inc | — | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Ablation System | ||||||
| 11/15/2023 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $12.96 | General |
| 11/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: Biological | ||||||
| 10/24/2023 | ABBVIE INC. | ORILISSA (Drug), LO LOESTRIN FE | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: WOMENS HEALTH | ||||||
| 10/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena, Skyla | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Womens Health | ||||||
| 10/02/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/28/2023 | Meditrina | — | Food and Beverage | Cash or cash equivalent | $13.65 | General |
| 09/27/2023 | Aspira Women's Health Inc | OVA1 (Device) | Food and Beverage | In-kind items and services | $51.92 | General |
| Category: OB/GYN | ||||||
| 09/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 303 | 1,621 | $65,920 | $37,508 |
| 2022 | 8 | 283 | 1,410 | $57,630 | $31,941 |
| 2021 | 6 | 238 | 324 | $28,790 | $17,280 |
| 2020 | 8 | 343 | 419 | $38,315 | $21,744 |
Total Patients
1,167
Total Services
3,774
Medicare Billing
$108,473
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,260 | $37,800 | $22,919 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 84 | 134 | $13,400 | $6,978 | 52.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 48 | $6,720 | $3,640 | 54.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 48 | 48 | $2,400 | $1,557 | 64.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 18 | 19 | $3,325 | $1,373 | 41.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 18 | 18 | $810.00 | $639.36 | 78.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 65 | 73 | $730.00 | $242.62 | 33.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 14 | 21 | $735.00 | $159.63 | 21.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 1,080 | $32,400 | $18,227 | 56.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 112 | 150 | $15,000 | $8,049 | 53.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 29 | $4,060 | $2,314 | 57.0% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 13 | 13 | $2,275 | $1,062 | 46.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 27 | 27 | $1,215 | $983.01 | 80.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 28 | 28 | $1,400 | $943.18 | 67.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 54 | 65 | $650.00 | $216.49 | 33.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 18 | $630.00 | $146.00 | 23.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 106 | 180 | $18,000 | $10,673 | 59.3% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 26 | 34 | $5,250 | $2,626 | 50.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 53 | 53 | $2,650 | $1,969 | 74.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 13 | $1,820 | $1,192 | 65.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 18 | 18 | $810.00 | $729.54 | 90.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 22 | 26 | $260.00 | $90.48 | 34.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 120 | 179 | $16,770 | $8,889 | 53.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 39 | 52 | $7,800 | $4,292 | 55.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 19 | 19 | $3,230 | $1,936 | 59.9% |
About Dr. Eleanor Murray, M.D
Dr. Eleanor Murray, M.D is a Obstetrics & Gynecology healthcare provider based in Huntsville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770780470.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eleanor Murray, M.D has received a total of $4,365 in payments from pharmaceutical and medical device companies, with $293.40 received in 2024. These payments were reported across 244 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($3,913).
As a Medicare-enrolled provider, Murray has provided services to 1,167 Medicare beneficiaries, totaling 3,774 services with total Medicare billing of $108,473. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Huntsville, AL
- Active Since 06/27/2007
- Last Updated 05/09/2024
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1770780470
Products in Payments
- PREMARIN (Drug) $305.88
- MYFEMBREE (Drug) $266.83
- LO LOESTRIN FE (Drug) $257.88
- INTRAROSA (Drug) $176.93
- Veozah (Drug) $164.69
- Xulane (Drug) $127.69
- Saxenda (Drug) $125.71
- XENFORM SOFT TISSUE REPAIR MATRIX (Device) $121.43
- Osphena (Drug) $120.72
- ORILISSA (Drug) $113.06
- OVA1 (Device) $106.78
- SLYND (Drug) $106.56
- MYRBETRIQ (Drug) $98.09
- INJECTAFER (Drug) $86.11
- Orilissa (Drug) $76.49
- PREMARIN ORALS (Drug) $72.71
- NUVARING (Drug) $64.83
- IMVEXXY (Drug) $62.94
- Prolia (Biological) $56.00
- Ultra 2.0 (Device) $54.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Huntsville
David Rushing, M.d, M.D
Obstetrics & Gynecology — Payments: $5,927
Obstetrics & Gynecology $5,927
John Wheeler, M.d, M.D
Obstetrics & Gynecology — Payments: $5,285
Obstetrics & Gynecology $5,285
Krishna Kakani, Md, MD
Obstetrics & Gynecology — Payments: $4,931
Obstetrics & Gynecology $4,931
Anne Marie Reidy, Md, MD
Obstetrics & Gynecology — Payments: $4,572
Obstetrics & Gynecology $4,572
Dr. Kevin Mcintosh, M.d, M.D
Obstetrics & Gynecology — Payments: $4,569
Obstetrics & Gynecology $4,569
Mr. Timothy Deahl, M.d, M.D
Obstetrics & Gynecology — Payments: $4,185
Obstetrics & Gynecology $4,185